INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
PATIENT REVENUES, NET	$ 113,360	$ 119,987
OTHER OPERATING INCOME	11,321	0
EXPENSES:
Operating	96,829	94,859
Lease and rent expense	13,249	13,512
Professional liability	2,083	1,839
General and administrative	6,765	6,758
Depreciation and amortization	2,295	2,288
Total expenses	121,221	119,256
OPERATING INCOME	3,460	731
OTHER INCOME (EXPENSE):
Other income	39	115
Interest expense, net	(1,022)	(1,460)
Total other expense	(983)	(1,345)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	2,477	(614)
(PROVISION) BENEFIT FOR INCOME TAXES	(343)	104
INCOME (LOSS) FROM CONTINUING OPERATIONS	2,134	(510)
LOSS FROM DISCONTINUED OPERATIONS:
Operating loss, net of tax benefit	(246)	(243)
NET INCOME (LOSS)	$ 1,888	$ (753)
Per common share – basic
Continuing operations (in dollars per share)	$ 0.33	$ (0.08)
Discontinued operations (in dollars per share)	(0.04)	(0.04)
Net income (loss) per common share – basic (in dollars per share)	0.29	(0.12)
Per common share – diluted
Continuing operations (in dollars per share)	0.32	(0.08)
Discontinued operations (in dollars per share)	(0.04)	(0.04)
Net income (loss) per common share – diluted (in dollars per share)	$ 0.28	$ (0.12)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (in shares)	6,573	6,506
Diluted (in shares)	6,741	6,506